9926:HKG
Akeso Inc
၉၂.၂၀ HK$
arrow_upward
+၀.၉၉%(+၀.၉၀) 1D
အောက် ၂၀, GMT+၈ ၁၀:၁၉:၁၈ · HKD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 9926...
Open
၉၁.၆၀ HK$
High
၉၃.၂၀ HK$
Low
၉၀.၃၅ HK$
Mkt. cap
ဋေ ၈.၅၀ ထ
Avg. vol.
၁.၁၂ ကုဋေ
Volume
၂.၉၃ သန်း
52-wk high
၁၅၆.၀၀ HK$
52-wk low
၈၀.၂၀ HK$
EPS
-၁.၂၄ HK$
No. of employees
၄ ထောင်
Open
၉၁.၆၀ HK$
High
၉၃.၂၀ HK$
Low
၉၀.၃၅ HK$
Mkt. cap
ဋေ ၈.၅၀ ထ
Avg. vol.
၁.၁၂ ကုဋေ
Volume
၂.၉၃ သန်း
52-wk high
၁၅၆.၀၀ HK$
52-wk low
၈၀.၂၀ HK$
EPS
-၁.၂၄ HK$
No. of employees
၄ ထောင်
News stories
From web sources and news partners
Simply Wall Street
·
ပြီးခဲ့သည့် ၁၆ နာရီ
Is Akeso (SEHK:9926) Undervalued On Its Phase III Colon Cancer Trial News?
Yahoo Finance
·
ပြီးခဲ့သည့် ၁ ရက်
Will Phase III Colon Cancer Trial Change Akeso Stock Narrative
Profile
Akeso, Inc is a publicly listed Chinese biopharmaceutical company that is headquartered in Zhongshan, Guangdong.
It is best known for developing Ivonescimab, a cancer treatment antibody. Wikipedia
About Akeso Inc
CEOMichelle Xia | Michelle Xia
Employees၄.၀၈ ထောင်
Founded၂၀၁၂ မတ် ၁၉
Headquarters-
Sector-
Websiteakesobio.com